Investors

Specialized pharmaceutical company for creating market value through experience and innovation

Presentations

Poster presentation at ESMO 2023 (TU2218)

2023.10.03

File [tiumbio] esmo2023-tu2218_phase1a_poster (1).pdf

Poster presentation of TU2218, an oral immune-oncology therapy targeting TGF-beta and VEGF, at the European Society for Medical Oncology

(ESMO) 2023

list